Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Meloni

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
The International Journal of Lower Extremity Wounds|February 16, 2026
Could Soft Tissue Infection Influence the Outcomes of Diabetic Foot Osteomyelitis? Data from a Retrospective StudyMarco Meloni, Luigi Uccioli, Michela Di Venanzio, et al.
The International Journal of Lower Extremity Wounds|January 6, 2026
Small Artery Disease in Persons with Diabetic Foot Ulcers: Incidence, Characteristics, and OutcomesMarco Meloni, Daniele Morosetti, Luigi Uccioli, et al.
International Journal of Molecular Sciences|June 12, 2026
Correction: Marchetti et al. MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb Muscles. <i>Int. J. Mol. Sci</i>. 2020, <i>21</i>, 1733Micol Marchetti, Marco Meloni, Maryam Anwar, et al.
Journal of Clinical Medicine|December 17, 2024
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational StudiesLaura Rehak, Laura Giurato, Matteo Monami, et al.
The International Journal of Lower Extremity Wounds|August 7, 2025
Six-month Outcomes of Patients Admitted for Diabetic Foot AttackFederico Rolando Bonanni, Marco Meloni, Martina Salvi, et al.
Acta Diabetologica|May 27, 2025
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cellsMarco Meloni, Ermanno Bellizzi, Luigi Uccioli, et al.
International Journal of Molecular Sciences|March 7, 2020
MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb MusclesMicol Marchetti, Marco Meloni, Maryam Anwar, et al.
Journal of the American Heart Association|December 17, 2019
Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of FallotLucia Cocomello, Marco Meloni, Filippo Rapetto, et al.
The International Journal of Lower Extremity Wounds|August 21, 2020
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute NeveliaManuela Montanaro, Marco Meloni, Lucia Anemona, et al.
Haematologica|August 18, 2025
FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1qJiro Kikuchi, Naoki Osada, Sae Matsuoka, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
The International Journal of Lower Extremity Wounds|February 16, 2026
Could Soft Tissue Infection Influence the Outcomes of Diabetic Foot Osteomyelitis? Data from a Retrospective StudyMarco Meloni, Luigi Uccioli, Michela Di Venanzio, et al.
The International Journal of Lower Extremity Wounds|January 6, 2026
Small Artery Disease in Persons with Diabetic Foot Ulcers: Incidence, Characteristics, and OutcomesMarco Meloni, Daniele Morosetti, Luigi Uccioli, et al.
International Journal of Molecular Sciences|June 12, 2026
Correction: Marchetti et al. MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb Muscles. <i>Int. J. Mol. Sci</i>. 2020, <i>21</i>, 1733Micol Marchetti, Marco Meloni, Maryam Anwar, et al.
Journal of Clinical Medicine|December 17, 2024
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational StudiesLaura Rehak, Laura Giurato, Matteo Monami, et al.
The International Journal of Lower Extremity Wounds|August 7, 2025
Six-month Outcomes of Patients Admitted for Diabetic Foot AttackFederico Rolando Bonanni, Marco Meloni, Martina Salvi, et al.
Acta Diabetologica|May 27, 2025
Predictive factors of major amputation in patients with diabetic foot ulcers treated by peripheral blood mononuclear cellsMarco Meloni, Ermanno Bellizzi, Luigi Uccioli, et al.
International Journal of Molecular Sciences|March 7, 2020
MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb MusclesMicol Marchetti, Marco Meloni, Maryam Anwar, et al.
Journal of the American Heart Association|December 17, 2019
Long-Term Comparison Between Pulmonary Homograft Versus Bioprosthesis for Pulmonary Valve Replacement in Tetralogy of FallotLucia Cocomello, Marco Meloni, Filippo Rapetto, et al.
The International Journal of Lower Extremity Wounds|August 21, 2020
Macrophage Activation and M2 Polarization in Wound Bed of Diabetic Patients Treated by Dermal/Epidermal Substitute NeveliaManuela Montanaro, Marco Meloni, Lucia Anemona, et al.
Haematologica|August 18, 2025
FOXM1 down-regulation is a trigger of isatuximab-induced direct cell death in multiple myeloma cells with 1qJiro Kikuchi, Naoki Osada, Sae Matsuoka, et al.
Pageof 15